Literature DB >> 15235871

Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.

Motohiro Ishii1, Tamotsu Sugai, Wataru Habano, Shin-Ichi Nakamura.   

Abstract

BACKGROUND: The point mutations occurring in codons 12 and 13 of the Ki- ras gene are useful genetic markers to identify intratumoral heterogeneity. A single tumor crypt, which consists of monoclonal cells, can be obtained using the crypt isolation method. Ki- ras gene mutations have been examined using the crypt isolation method to determine whether multiclonarity is present within the same tumor.
METHODS: Ki- ras gene mutations were analyzed using a crypt isolation technique coupled with polymerase chain reaction and direct sequencing in 21 sporadic colorectal carcinomas. The specimens were divided into two groups: a representative sample, which was composed of more than 50 tumor crypts, and a single tumor crypt sample. The latter consisted of 10 single tumor crypts, which were obtained from the same tumor separately.
RESULTS: Ki- ras gene mutations were found in 11 of 21 representative samples and in 12 of 21 single tumor crypt samples. In the 11 samples with Ki- ras mutation, Ki- ras mutations were also found in most single tumor crypts. Among the 12 base substitutions found, G:C to A:T transitions were the most commonly observed. There were no differences between the two samples in the types of Ki- ras mutations found. One Ki- ras mutation that was not detected in the representative sample was observed in only a single tumor crypt.
CONCLUSIONS: Most carcinomas appear to have a homogeneous composition that may result from the successful progression of one of the clones having a Ki- ras mutation. Additional mutations in the Ki- ras gene were rarely observed in colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15235871     DOI: 10.1007/s00535-003-1340-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  5 in total

1.  Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.

Authors:  Satu Oltedal; Ole Gunnar Aasprong; Jannicke H Møller; Hartwig Kørner; Bjørnar Gilje; Kjersti Tjensvoll; Elke M Birkemeyer; Reino Heikkilä; Rune Smaaland; Oddmund Nordgård
Journal:  Int J Colorectal Dis       Date:  2011-05-15       Impact factor: 2.571

Review 2.  Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.

Authors:  Jara M Baas; Lisanne L Krens; Henk-Jan Guchelaar; Hans Morreau; Hans Gelderblom
Journal:  Oncologist       Date:  2011-07-08

Review 3.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 4.  Colorectal cancer: genetics of development and metastasis.

Authors:  Tetsuji Takayama; Koji Miyanishi; Tsuyoshi Hayashi; Yasushi Sato; Yoshiro Niitsu
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

5.  A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases.

Authors:  Eric Marks; Syed Mujtaba Rizvi; Nabeel Sarwani; Zhaohai Yang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.